2016 Q1 Form 10-Q Financial Statement
#000114420416099287 Filed on May 05, 2016
Income Statement
Concept | 2016 Q1 | 2015 Q1 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $2.430M | $1.710M |
YoY Change | 42.11% | 52.68% |
% of Gross Profit | ||
Research & Development | $8.155M | $6.494M |
YoY Change | 25.58% | 139.01% |
% of Gross Profit | ||
Depreciation & Amortization | $37.00K | $8.000K |
YoY Change | 362.5% | 166.67% |
% of Gross Profit | ||
Operating Expenses | $8.155M | $8.207M |
YoY Change | -0.63% | 113.78% |
Operating Profit | -$10.58M | -$8.207M |
YoY Change | 28.93% | 113.78% |
Interest Expense | $0.00 | $0.00 |
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | -$497.0K | -$4.151M |
YoY Change | -88.03% | -415200.0% |
Pretax Income | -$10.58M | -$8.207M |
YoY Change | 28.93% | 113.78% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$11.08M | -$12.36M |
YoY Change | -10.36% | 222.02% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | -$0.12 | -$0.17 |
Diluted Earnings Per Share | -$0.12 | -$0.17 |
COMMON SHARES | ||
Basic Shares Outstanding | 90.83M shares | 72.67M shares |
Diluted Shares Outstanding | 90.83M shares | 72.67M shares |
Balance Sheet
Concept | 2016 Q1 | 2015 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $15.10M | $12.05M |
YoY Change | 25.31% | 7.97% |
Cash & Equivalents | $15.10M | $12.05M |
Short-Term Investments | ||
Other Short-Term Assets | $7.116M | $1.574M |
YoY Change | 352.1% | 18.17% |
Inventory | ||
Prepaid Expenses | $374.0K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $22.22M | $13.62M |
YoY Change | 63.11% | 9.1% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $500.0K | $75.00K |
YoY Change | 566.67% | 97.37% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $30.00K | $20.00K |
YoY Change | 50.0% | 100.0% |
Total Long-Term Assets | $520.0K | $93.00K |
YoY Change | 459.14% | 111.36% |
TOTAL ASSETS | ||
Total Short-Term Assets | $22.22M | $13.62M |
Total Long-Term Assets | $520.0K | $93.00K |
Total Assets | $22.74M | $13.72M |
YoY Change | 65.79% | 9.46% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $4.600M | $1.559M |
YoY Change | 195.06% | 101.68% |
Accrued Expenses | $1.820M | $2.646M |
YoY Change | -31.22% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $17.53M | $15.34M |
YoY Change | 14.27% | 1884.61% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $240.0K | |
YoY Change | ||
Total Long-Term Liabilities | $240.0K | $0.00 |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $17.53M | $15.34M |
Total Long-Term Liabilities | $240.0K | $0.00 |
Total Liabilities | $16.49M | $15.34M |
YoY Change | 7.49% | 1884.61% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$113.4M | |
YoY Change | 33.26% | |
Common Stock | $111.8M | |
YoY Change | 15.41% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $6.260M | -$1.625M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $22.74M | $13.72M |
YoY Change | 65.79% | 9.46% |
Cashflow Statement
Concept | 2016 Q1 | 2015 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$11.08M | -$12.36M |
YoY Change | -10.36% | 222.02% |
Depreciation, Depletion And Amortization | $37.00K | $8.000K |
YoY Change | 362.5% | 166.67% |
Cash From Operating Activities | -$5.674M | -$5.458M |
YoY Change | 3.96% | 57.29% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $44.00K | $18.00K |
YoY Change | 144.44% | 350.0% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$44.00K | -$18.00K |
YoY Change | 144.44% | 350.0% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $0.00 | $0.00 |
YoY Change | -100.0% | |
NET CHANGE | ||
Cash From Operating Activities | -$5.674M | -$5.458M |
Cash From Investing Activities | -$44.00K | -$18.00K |
Cash From Financing Activities | $0.00 | $0.00 |
Net Change In Cash | -$5.718M | -$5.476M |
YoY Change | 4.42% | 57.81% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$5.674M | -$5.458M |
Capital Expenditures | $44.00K | $18.00K |
Free Cash Flow | -$5.718M | -$5.476M |
YoY Change | 4.42% | 57.63% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.12 | |
CY2015Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.17 | |
CY2015Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
563000 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
649000 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5458000 | USD |
CY2015Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
827000 | USD |
CY2015Q1 | us-gaap |
Depreciation
Depreciation
|
8000 | USD |
CY2016Q1 | us-gaap |
Depreciation
Depreciation
|
37000 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
26000 | USD |
CY2015Q1 | syn |
Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
|
12000 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1348000 | USD |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | |
CY2016Q1 | syn |
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
|
0 | |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
3.75 | |
CY2015 | syn |
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriod
|
2448 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
63447 | shares |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5674000 | USD |
CY2015Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
18000 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-18000 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-44000 | USD |
CY2015Q1 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
-5476000 | USD |
CY2016Q1 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
-5718000 | USD |
CY2015Q1 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2016Q1 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2015Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2016Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-310000 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
592000 | USD |
CY2016Q1 | syn |
Stock Issued For Milestone Payments
StockIssuedForMilestonePayments
|
0 | USD |
CY2015Q1 | syn |
Stock Issued For Milestone Payments
StockIssuedForMilestonePayments
|
-350000 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
1000 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
0 | USD |
CY2016Q1 | syn |
Prepaid Expenses Research And Development
PrepaidExpensesResearchAndDevelopment
|
307000 | USD |
CY2015Q4 | syn |
Prepaid Expenses Research And Development
PrepaidExpensesResearchAndDevelopment
|
643000 | USD |
CY2016Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
224000 | USD |
CY2015Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
339000 | USD |
CY2016Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
425000 | USD |
CY2015Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
208000 | USD |
CY2016Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
7116000 | USD |
CY2015Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
9519000 | USD |
CY2016Q1 | syn |
Prepaid Clinical Research Organizations
PrepaidClinicalResearchOrganizations
|
6160000 | USD |
CY2015Q4 | syn |
Prepaid Clinical Research Organizations
PrepaidClinicalResearchOrganizations
|
8329000 | USD |
CY2016Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
123000 | USD |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
105000 | USD |
CY2015Q4 | syn |
Accrued Manufacturing Costs
AccruedManufacturingCosts
|
0 | USD |
CY2016Q1 | syn |
Accrued Manufacturing Costs
AccruedManufacturingCosts
|
2000 | USD |
CY2015Q4 | syn |
Accrued Vendor Payments
AccruedVendorPayments
|
133000 | USD |
CY2016Q1 | syn |
Accrued Vendor Payments
AccruedVendorPayments
|
388000 | USD |
CY2015Q4 | syn |
Accrued Clinical Consulting Services
AccruedClinicalConsultingServices
|
164000 | USD |
CY2016Q1 | syn |
Accrued Clinical Consulting Services
AccruedClinicalConsultingServices
|
556000 | USD |
CY2016Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
7300000 | USD |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
0 | shares |
CY2016Q1 | syn |
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriod
|
0 | shares |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
50000 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
0 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | |
CY2015 | syn |
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
|
1.6 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
1.79 | |
CY2016Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2016Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2016Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2016Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
CY2016Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
90908234 | shares |
CY2016Q1 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
6900000 | USD |
CY2015Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
5300000 | USD |
CY2016Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
624000 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
599000 | USD |
CY2015Q1 | syn |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionExercisePrice
|
1.54 | |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.17 | pure |
CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.31 | pure |
CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0203 | pure |
CY2016Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P7Y | |
CY2015Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.77 | |
CY2015Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
277000 | USD |
CY2016Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
90826752 | shares |
CY2016Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8992428 | shares |
CY2015Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6531106 | shares |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17525000 | USD |
CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12049000 | USD |
CY2015Q1 | syn |
Warrant Liabilities
WarrantLiabilities
|
10900000 | USD |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7974794 | shares |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7908899 | shares |
CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7858899 | shares |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.80 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.79 | |
CY2016Q1 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
355000 | USD |
CY2015Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
0 | USD |
CY2016Q1 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
248000 | USD |
CY2015Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
153000 | USD |
CY2016Q1 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
266000 | USD |
CY2015Q4 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
124000 | USD |
CY2016Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
869000 | USD |
CY2015Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
72673959 | shares |